ArticleNanomaterials (Basel, Switzerland)2020

Harnessing the Activation of Toll-Like Receptor 2/6 by Self-Assembled Cross-β Fibrils to Design Adjuvanted Nanovaccines.

Soultan Al-Halifa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.